Results
|
61.
|
|
|
62.
|
|
|
63.
|
|
|
64.
|
|
|
65.
|
|
|
66.
|
Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). [electronic resource] by
- Bretthauer, M
- Gondal, G
- Larsen, K
- Carlsen, E
- Eide, T J
- Grotmol, T
- Skovlund, E
- Tveit, K M
- Vatn, M H
- Hoff, G
Producer: 20021206
In:
Scandinavian journal of gastroenterology vol. 37
Availability: No items available.
|
|
67.
|
|
|
68.
|
Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer. [electronic resource] by
- Glimelius, B
- Ristamäki, R
- Kjaer, M
- Pfeiffer, P
- Skovsgaard, T
- Tveit, K M
- Linné, T
- Frödin, J E
- Boussard, B
- Oulid-Aïssa, D
- Pyrhönen, S
Producer: 20030411
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 13
Availability: No items available.
|
|
69.
|
Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil. [electronic resource] by
- Pfeiffer, P
- Sørbye, H
- Ehrsson, H
- Fokstuen, T
- Mortensen, J P
- Baltesgard, L
- Tveit, K M
- Øgreid, D
- Starkhammar, H
- Wallin, I
- Qvortrup, C
- Glimelius, B
Producer: 20070620
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 17
Availability: No items available.
|
|
70.
|
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. [electronic resource] by
- Kjersem, J B
- Thomsen, M
- Guren, T
- Hamfjord, J
- Carlsson, G
- Gustavsson, B
- Ikdahl, T
- Indrebø, G
- Pfeiffer, P
- Lingjærde, O
- Tveit, K M
- Wettergren, Y
- Kure, E H
Producer: 20170309
In:
The pharmacogenomics journal vol. 16
Availability: No items available.
|
|
71.
|
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. [electronic resource] by
- Fluge, Ø
- Gravdal, K
- Carlsen, E
- Vonen, B
- Kjellevold, K
- Refsum, S
- Lilleng, R
- Eide, T J
- Halvorsen, T B
- Tveit, K M
- Otte, A P
- Akslen, L A
- Dahl, O
Producer: 20091028
In:
British journal of cancer vol. 101
Availability: No items available.
|
|
72.
|
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy. [electronic resource] by
- Hamfjord, J
- Guren, T K
- Dajani, O
- Johansen, J S
- Glimelius, B
- Sorbye, H
- Pfeiffer, P
- Lingjærde, O C
- Tveit, K M
- Kure, E H
- Pallisgaard, N
- Spindler, K-L G
Producer: 20200623
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|
|
73.
|
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. [electronic resource] by
- Myklebust, M P
- Li, Z
- Tran, T H
- Rui, H
- Knudsen, E S
- Elsaleh, H
- Fluge, Ø
- Vonen, B
- Myrvold, H E
- Leh, S
- Tveit, K M
- Pestell, R G
- Dahl, O
Producer: 20130401
In:
British journal of cancer vol. 107
Availability: No items available.
|
|
74.
|
Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. [electronic resource] by
- Andersen, T I
- Eiken, H G
- Couch, F
- Kaada, G
- Skrede, M
- Johnsen, H
- Aloysius, T A
- Tveit, K M
- Tranebjaerg, L
- Dørum, A
- Møller, P
- Weber, B L
- Børresen-Dale, A L
Producer: 19980327
In:
Human mutation vol. 11
Availability: No items available.
|
|
75.
|
Screening for ESR mutations in breast and ovarian cancer patients. [electronic resource] by
- Anderson, T I
- Wooster, R
- Laake, K
- Collins, N
- Warren, W
- Skrede, M
- Elles, R
- Tveit, K M
- Johnston, S R
- Dowsett, M
- Olsen, A O
- Møller, P
- Stratton, M R
- Børresen-Dale, A L
Producer: 19970822
In:
Human mutation vol. 9
Availability: No items available.
|
|
76.
|
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer. [electronic resource] by
- Schoemaker, N E
- Kuppens, I E L M
- Moiseyenko, V
- Glimelius, B
- Kjaer, M
- Starkhammer, H
- Richel, D J
- Smaaland, R
- Bertelsen, K
- Poulsen, J P
- Voznyi, E
- Norum, J
- Fennelly, D
- Tveit, K M
- Garin, A
- Gruia, G
- Mourier, A
- Sibaud, D
- Lefebvre, P
- Beijnen, J H
- Schellens, J H M
- ten Bokkel Huinink, W W
Producer: 20041116
In:
British journal of cancer vol. 91
Availability: No items available.
|